Table 4 The costs and cost-effectiveness in each group, urban and rural
Urban | Rural | |||
|---|---|---|---|---|
Analysis | Intervention | Control | Intervention | Control |
ITT analysis | ||||
Cost ($) | ||||
Anti-hypertensive drugs | 8964.1 | 13 241.0 | 5082.4 | 7515.1 |
Salary costs of primary healthcare providers | 379.3 | 223.1 | 227.5 | 133.9 |
Training | 906.1 | 0.0 | 1002.8 | 0.0 |
Administration | 797.4 | 425.3 | 894.0 | 531.6 |
CMR | 50.7 | 50.7 | 50.7 | 50.7 |
Total ($) | 11 097.6 | 13 940.1 | 7257.5 | 8231.3 |
Average cost per patient ($) | 79.3 | 99.6 | 51.8 | 58.8 |
Incremental cost per patient ($) | −20.3 | −7.0 | ||
PP analysis | ||||
Cost ($) | ||||
Anti-hypertensive drugs | 7042.2 | 8929.4 | 4908.8 | 6464.8 |
Salary costs of primary healthcare providers | 379.3 | 223.1 | 227.5 | 133.9 |
Training | 906.1 | 0.0 | 1002.8 | 0.0 |
Administration | 797.4 | 425.3 | 894.0 | 531.6 |
CMR | 38.8 | 30.4 | 47.8 | 41.0 |
Total ($) | 9163.8 | 9608.2 | 7080.9 | 7171.3 |
Average cost per patient ($) | 85.6 | 114.4 | 53.6 | 63.5 |
Incremental cost per patient ($) | −28.7 | −9.8 | ||
